Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Sept 2026 for Knight Therapeutics Inc., €2,103. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Samira Sakhia: trading record in brief
Samira Sakhia has filed trades across 2 companies (mainly through SEDI), most often in Knight Therapeutics Inc. and Dollarama Inc. Over a trading history stretching from 15 June 2026 to 15 September 2026, the count stands at 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 18 September 2026, the filings show a share grant worth €2,103 in Knight Therapeutics Inc. Filings reach the SEDI feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to Samira Sakhia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
600 shares@ CA$5.63Common SharesTSXSEDI:4778908
1,581 shares@ CA$9.87Common SharesTSXSEDI:4778907
6 shares@ CA$191.3450.0000% mcap100.0% of flowDeferred Share Units (DSU)TSXSEDI:4763208
126 sharesDeferred Share Units (DSU)TSXSEDI:4760132
720 shares@ CA$5.220.0004% mcap17.2% of flowCommon SharesTSXSEDI:4736911
1,934 shares@ CA$9.360.0019% mcap82.8% of flowCommon SharesTSXSEDI:4736910
6 of 6 declarations
